We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aptorum Group

News List

Aptorum to investigate use of repurposed drug candidates for coronavirus pharmaceutical-business-review
April 02, 2020
Aptorum Group has joined forces with Covar Pharmaceuticals for studying the use of three repurposed drug candidates for the treatment of novel coronavirus (COVID-19).
Aptorum and Covar explore repurposed drugs for coronavirus pharmaceutical-technology
April 01, 2020
Aptorum Group is set to choose at least three repurposed drug candidates for Covid-19 treatment, out of nearly 2,600 approved small drug molecules screened using its Smart-ACT drug discovery platform.
Aptorum Group Limited announces appointment of Head of R&D and COO biospectrumasia
April 03, 2019
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr. Angel Siu-yan Ng as Chief Operating Officer of Aptorum, effective on April 1, 2019.